![Edita Mistiniene](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edita Mistiniene worked as Director of Research and Development at 3P Biopharmaceuticals SL from 2014 to 2017.
Prior to that, she was the Chief Scientist and Head of Research and Development at Teva Pharmaceutical Industries Ltd. Dr. Mistiniene received her graduate and doctorate degrees from Vilnius University.
| Bedrijven | Functie | Einde |
|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Hoofd Techniek/Wetenschap/O&O | 02-01-2017 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Vilnius University
 Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
